TY - JOUR
T1 - Serum neurofilament light chain and optical coherence tomography measures in MS
T2 - A longitudinal study
AU - Tavazzi, Eleonora
AU - Jakimovski, Dejan
AU - Kuhle, Jens
AU - Hagemeier, Jesper
AU - Ozel, Osman
AU - Ramanathan, Murali
AU - Barro, Christian
AU - Bergsland, Niels
AU - Tomic, Davorka
AU - Kropshofer, Harald
AU - Leppert, David
AU - Michalak, Zuzanna
AU - Lincoff, Norah
AU - Dwyer, Michael G.
AU - Benedict, Ralph H.B.
AU - Weinstock-Guttman, Bianca
AU - Zivadinov, Robert
N1 - Publisher Copyright:
© American Academy of Neurology.
PY - 2020/7/18
Y1 - 2020/7/18
N2 - ObjectiveTo study the association between serum neurofilament light chain (sNfL) and multiple optical coherence tomography (OCT) measures in patients with MS and healthy controls (HCs).MethodsIn this prospective study, 110 patients with MS were recruited, together with 52 age- and sex-matched HCs. Clinical evaluation and spectral domain OCT and sNfL were obtained at baseline and after 5.5 years of follow-up. Nested linear mixed models were used to assess differences between MS vs HC and associations between sNfL and OCT measures. Partial correlation coefficients are reported, and p values were adjusted for the false discovery rate.ResultsAt baseline, peripapillary retinal nerve fiber layer thickness (pRNFLT) and macular ganglion cell and inner plexiform layer thickness (mGCIP) were significantly lower in MS than HC both in MS-associated optic neuritis (MSON) (p = 0.007, p = 0.001) and nonaffected MSON (n-MSON) eyes (p = 0.003, p = 0.018), along with total macular volume (TMV) in n-MSON eyes (p = 0.011). At follow-up, MS showed significantly lower pRNFLT, mGCIP, and TMV both in MSON and n-MSON eyes (p < 0.001) compared with HC. In MS n-MSON eyes, sNfL was significantly associated with baseline pRNFLT and mGCIP (q = 0.019). No significant associations were found in MSON eyes.ConclusionsThis study confirms the ability of sNfL to detect neurodegeneration in MS and advocates for the inclusion of sNfL and OCT measures in clinical trials.Classification of evidenceThis study provides Class III evidence that sNfL levels were associated with MS neurodegeneration measured by OCT.
AB - ObjectiveTo study the association between serum neurofilament light chain (sNfL) and multiple optical coherence tomography (OCT) measures in patients with MS and healthy controls (HCs).MethodsIn this prospective study, 110 patients with MS were recruited, together with 52 age- and sex-matched HCs. Clinical evaluation and spectral domain OCT and sNfL were obtained at baseline and after 5.5 years of follow-up. Nested linear mixed models were used to assess differences between MS vs HC and associations between sNfL and OCT measures. Partial correlation coefficients are reported, and p values were adjusted for the false discovery rate.ResultsAt baseline, peripapillary retinal nerve fiber layer thickness (pRNFLT) and macular ganglion cell and inner plexiform layer thickness (mGCIP) were significantly lower in MS than HC both in MS-associated optic neuritis (MSON) (p = 0.007, p = 0.001) and nonaffected MSON (n-MSON) eyes (p = 0.003, p = 0.018), along with total macular volume (TMV) in n-MSON eyes (p = 0.011). At follow-up, MS showed significantly lower pRNFLT, mGCIP, and TMV both in MSON and n-MSON eyes (p < 0.001) compared with HC. In MS n-MSON eyes, sNfL was significantly associated with baseline pRNFLT and mGCIP (q = 0.019). No significant associations were found in MSON eyes.ConclusionsThis study confirms the ability of sNfL to detect neurodegeneration in MS and advocates for the inclusion of sNfL and OCT measures in clinical trials.Classification of evidenceThis study provides Class III evidence that sNfL levels were associated with MS neurodegeneration measured by OCT.
UR - https://www.scopus.com/pages/publications/85084897282
U2 - 10.1212/NXI.0000000000000737
DO - 10.1212/NXI.0000000000000737
M3 - Article
C2 - 32424064
AN - SCOPUS:85084897282
SN - 2332-7812
VL - 7
SP - E737
JO - Neurology: Neuroimmunology and NeuroInflammation
JF - Neurology: Neuroimmunology and NeuroInflammation
IS - 4
ER -